Following an application from BENEO-Orafti S.A., submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 and including a request for protection of proprietary data, the Authority was required to deliver an opinion on the scientific substantiation of a health claim related to native chicory inulin and maintenance of normal defecation by increasing stool frequency (Question No EFSA-Q-2014-00403 [EFSA Journal 2015;13(1):3951.]). The claim proposed by the applicant was worded, inter alia, as follows: ‘Orafti®Inulin improves bowel function’.
Recital 6, Regulation (EU) 2015/2314
In forcesince 7 Dec 2015